TURTLE CAMERON (Chief Executive Officer) sold 2.4% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.06M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/4/2026ACC: 0001636282-26-000077
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.06M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.56K
Price / share
$69.40
Trade value
$246.86K
% of position
0.6%
6/1/2026
612.54K→608.98K
Common Stock
Direct
Shares
−8.15K
Price / share
$70.50
Trade value
$574.50K
% of position
1.3%
6/1/2026
608.98K→600.83K
Common Stock
Direct
Shares
−3.29K
Price / share
$71.38
Trade value
$235.13K
% of position
0.5%
6/1/2026
600.83K→597.54K
Total
Net shares
−15K
Net value
-$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −3.56K | $69.40 | $246.86K | 0.6% | 612.54K | 608.98K |
| Common Stock Direct | 6/1/2026 | S · Sale | −8.15K | $70.50 | $574.50K | 1.3% | 608.98K | 600.83K |
| Common Stock Direct | 6/1/2026 | S · Sale | −3.29K | $71.38 | $235.13K | 0.5% | 600.83K | 597.54K |
| Total | −15K | -$1.06M | ||||||
Derivative Transactions0
No derivative transactions reported